| ?? |
?? ?? |
CAS |
MF |
 |
Ciprofloxacin-D8 hydrochloride hydrate (see Data Sheet) |
1216659-54-9 |
C17H11ClD8FN3O3 |
 |
TrifluproMazine Hydrochloride-d6 |
1416711-36-8 |
C18H20ClF3N2S |
 |
hydroxocobalamin monohydrochloride |
59461-30-2 |
C62H89ClCoN13O15P |
 |
Robenidine-d8 HCl |
1173097-77-2 |
C15H14Cl3N5 |
 |
SulfaMonoMethoxine-13C6 hydrate (see Data Sheet) |
1416768-32-5 |
|
 |
BENZOYL NORECGONINE |
41889-45-6 |
C15H17NO4 |
 |
Toltrazuril sulfone-D3
Ponazuril-D3 |
1346602-48-9 |
C18H14F3N3O6S |
 |
Benzoylecgonine tetrahydrate
|
5928-96-1 |
C16H21NO5 |
 |
Xylazine-D6 |
1228182-53-3 |
C12H16N2S |
 |
Pirbuterol-D9 acetate |
1431291-46-1 |
C14H24N2O5 |
 |
5-ALLYL-5-ISOBUTYLBARBITURIC ACID-RING-13C4 |
|
C11H16N2O3 |
 |
Albendazole sulfoxide-D3
Ricobendazole-D3 |
1448346-38-0 |
C12H12D3N3O3S |
 |
HydroxyMethylclenbuterol hydrochloride |
37162-89-3 |
C12H19Cl3N2O2 |
 |
cis-Tamoxifen-13C2,15N solution
|
|
C26H29NO |
 |
rac AMphetaMine Hydrochloride |
2706-50-5 |
C9H14ClN |
 |
PropionylproMazine-D6 hydrochloride |
1262770-67-1 |
C20H25ClN2OS |
 |
Cyclopentylalbendazole sulfone |
1448346-31-3 |
C14H17N3O4S |
|
|
AMINO ACID STANDARD |
|
|
|
|
Megestrol Acetate IMpurity K |
|
|
|
|
MeloxicaM Related CoMpound D |
|
|
|
|
Abacavir StereoisoMers Mixture |
|
|
 |
CHLORAMPHENICOL DISODIUM DISUCCINATE |
|
C19H20Cl2N2Na2O13-2 |
![3-[1-hydroxy-4-[4-(hydroxydiphenylMethyl)-1-piperidinyl]butyl]-alpha,alpha-diMethyl benzeneacetic acid hydrochloride](/CAS/20200119/GIF/CB12541748.gif) |
3-[1-hydroxy-4-[4-(hydroxydiphenylMethyl)-1-piperidinyl]butyl]-alpha,alpha-diMethyl benzeneacetic acid hydrochloride |
|
C32H40ClNO4 |
|
|
EUROSOIL 5 |
|
|
|
|
Hemoglobin HbA0 (non-glycated) |
|
|
 |
OXOLINIC ACID IMPURITY A |
26893-27-6 |
C11H7NO5 |
|
|
CLOSANTEL SODIUM DIHYDRATE |
|
|
|
|
Anastrozole iMpurity E |
|
|
|
|
CitalopraM Related CoMpound G |
|
|
|
|
Levothyroxine for Peak Identification |
|
|
|
|
Orlistat Related CoMpound E |
|
|
|
|
Pharmaceutical glass containers (Alkali leaching and release) |
|
|
|
|
DIPHENOXYLATE HYDROCHLORIDE - REFERENCE SPECTRUM |
|
|
 |
TIAPRIDE N-OXIDE |
63484-11-7 |
C15H24N2O5S |
|
|
POLYGLYCERYL-3 DIISOSTEARATE |
66082-42-6 |
C45H88O9 |
|
|
Silicon (isotope ratio) |
|
|
|
|
RETINOL ESTERS |
|
|
|
|
Vitamin D Assay System Suitability |
|
|
 |
Colterol-D9 acetate |
1420043-63-5 |
C14H23NO5 |
 |
Copper-65Cu solution |
|
Cu |
 |
Chloroquine Related CoMpound E |
5428-61-5 |
C18H26ClN3 |
 |
ALLOPURINOL IMPURITY A |
|
C5H4N4O |
|
|
FLUMAZENIL - REFERENCE SPECTRUM |
|
|
|
|
Boric acid (isotope ratio) |
|
|
|
|
CALCIUM ASCORBATE - REFERENCE SPECTRUM |
|
|
 |
TICARCILLIN IMPURITY A |
6933-26-2 |
C13H12OS |
|
|
TYLOSIN PHOSPHATE FOR PEAK IDENTIFICATION |
|
|
 |
Cefoperazone dihydrate |
113826-44-1 |
C25H29N9O9S2 |
 |
Iron-56Fe solution |
|
Fe |
 |
?????????G(15-mg)(7-???-1,4-???-5-??-4,5-????-1H-1,4-??????-2,3-??) |
93329-92-1 |
C17H15ClN2O2 |
 |
Ranitidine Resolution Mixture |
|
C13H22N4O3S |
|
|
HYDROUS BENZOYL PEROXIDE - REFERENCE SPECTRUM |
|
|
|
|
HEPARIN LOW-MOLECULAR-MASS FOR CALIBRATION CRS |
|
|
 |
82999, 237NpO2 (V encapsulated) |
58670-16-9 |
NpO2 |
|
|
Medroxyprogesterone Acetate Related CoMpound A |
|
|
|
|
EUROSOIL 2 |
|
|
 |
DIPHENHYDRAMINE IMPURITY A |
|
C17H21NO |
|
|
TRANS-EPOXYPHYTOMENADIONE |
|
|
|
|
Cefprozil Related CoMpound K |
|
|
 |
Abacavir Related CoMpound D |
1443421-69-9 |
C18H21ClN10O |
|
|
Enrofloxacin Related CoMpound Mixture |
|
|
|
|
DICLAZURIL FOR VETERINARY USE - REFERENCE SPECTRUM |
|
|
|
|
TRICLOSAN RELATED COMPOUNDS MIXTURE A (1.2 ML/AMPULE; 3 AMPULES) |
|
|
 |
picotamide monohydrate |
80530-63-8 |
|
|
|
EUROSOIL 4 |
|
|
|
|
Human serum (high creatinine) |
|
|
-6-cyano-1(3H)-isobenzofuranone oxalate](/CAS/20200119/GIF/CB32541601.gif) |
3-[3-(diMethylaMino)-1-propyl](4-fluorophenyl)-6-cyano-1(3H)-isobenzofuranone oxalate |
|
C22H21FN2O6 |
|
|
EUROSOIL 1 |
|
|
 |
Cadmium-111Cd solution |
|
Cd |
|
|
Lithium carbonate-7Li |
|
7Li2CO3 |
![Rosiglitazone Related Compound A (25 mg) ((5Z)-5-{[4-({2-[methyl(2-pyridinyl)amino]ethyl}oxy)phenyl]methylidene}-1,3-thiazolidine-2,4-dione)](/CAS/20200515/GIF/160596-25-8.gif) |
Rosiglitazone Related Compound A (25 mg) ((5Z)-5-{[4-({2-[methyl(2-pyridinyl)amino]ethyl}oxy)phenyl]methylidene}-1,3-thiazolidine-2,4-dione) |
160596-25-8 |
C18H17N3O3S |
|
|
ACECLOFENAC - REFERENCE SPECTRUM |
|
|
 |
1-(3,4-dichlorophenyl)-5-isopropylbiguanide monohydrochloride |
6001-93-0 |
C11H16Cl3N5 |
 |
Triprolidine Hydrochloride Z-IsoMer |
51657-91-1 |
C19H23ClN2 |
 |
SalMeterol Resolution Check |
|
C25H37NO4 |
 |
IFOSFAMIDE IMPURITY E |
42453-19-0 |
C5H11Cl2N |
|
|
PANCREAS POWDER (PROTEASE) BRP |
|
|
|
|
OXFENDAZOLE WITH IMPURITY D |
|
|
|
|
GMO Standard ERM-BF411, Maize Bt-176 |
|
|
 |
Temazepam Related Compound F (15 mg) (7-chloro-1-methyl-5-phenyl-4,5-dihydro-1H-1,4-benzodiazepine-2,3-dione) |
3294-96-0 |
C16H13ClN2O2 |
|
|
EUROSOIL 3 |
|
|
 |
Boron-11B solution |
|
BH3 |
|
|
Platinum (isotope ratio) |
|
|
|
|
CeftazidiMe, Delta-3-IsoMer |
|
|
|
|
OMeprazole Related CoMpound F and G Mixture |
|
|
|
|
Pyrantel Related CoMpound A |
|
|
 |
SulfaMethoxazole Related CoMpound F |
17103-52-5 |
C10H11N3O3S |
 |
IFOSFAMIDE IMPURITY B |
241482-18-8 |
C10H24Cl2N2O7P2 |
|
|
Lamivudine Resolution Mixture B |
|
|
|
|
Vancomycin B with Monodechlorovancomycin |
|
|
 |
137234-62-9 |
137234-62-9 |
C16H14F3N5O |
 |
Rubidium-85Rb solution |
|
Rb |
 |
Cefadroxil Related CoMpound I |
147103-94-4 |
C16H17N3O5S |
|
|
Cefprozil Related CoMpound H |
|
|
|
|
TRIMETHOPRIM IMPURITY B |
|
|
|
|
MetaMizole iMpurity E |
|
|
|
|
GalantaMine HydrobroMide Related CoMpounds Mixture |
|
|
 |
Flutrimazole carbinol |
128092-72-8 |
C19H14F2O |
|
|
ENDOTOXIN STANDARD |
|
|
|
|
POTASSIUM CLAVULANATE - REFERENCE SPECTRUM |
|
|